Skip Navigation



Journal of the National Cancer Institute Advance Access published online on November 27, 2007
JNCI Journal of the National Cancer Institute, doi:10.1093/jnci/djm245
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
99/23/1741    most recent
djm245v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Giaccone, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giaccone, G.
Related Collections
Right arrowRelated Articles in JNCI
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press.

EDITORIALS

18Fluorodeoxyglucose Positron Emission Tomography, a Standard Diagnostic Tool in Lung Cancer

Giuseppe Giaccone

Affiliation of author: Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD

Correspondence to: Giuseppe Giaccone, PhD, Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD (e-mail: giacconeg@mail.nih.gov).

The first 10% of the full text of this article appears below.

18Fluorodeoxyglucose positron emission tomography (FDG-PET) has entered routine use in the management of lung cancer, at least in countries and health systems that can afford it. FDG-PET has better sensitivity than computed tomography (CT) scanning in the detection of distant metastases in patients with non–small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). However, the relatively low specificity of FDG-PET and the difficulty in localizing the "hot spots" identified by FDG-PET imaging have elicited efforts to integrate FDG-PET with other radiologic imaging techniques, such as CT scans.

In this issue of the Journal, Ung et al. (1) present an extensive systematic review of the published literature on the accuracy and utility of FDG-PET in the diagnosis and staging of lung cancer. The authors focus on three areas: 1) use of FDG-PET in . . . [Full Text of this Article]

Solitary Pulmonary Nodules

Preoperative Staging of Non–Small Cell Lung Cancer

Staging of Small Cell Lung Cancer


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Articles in JNCI

18Fluorodeoxyglucose Positron Emission Tomography in the Diagnosis and Staging of Lung Cancer: A Systematic Review
Yee C. Ung, Donna E. Maziak, Jessica A. Vanderveen, Christopher A. Smith, Karen Gulenchyn, Christina Lacchetti, William K. Evans, and Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-Based Care
J Natl Cancer Inst 2007 99: 1753-1767. [Abstract] [Full Text] [PDF]

IN THIS ISSUE
J Natl Cancer Inst 2007 99: 1737. [Extract] [Full Text] [PDF]

Press Release: PET Imaging May Improve Lung Cancer Diagnosis
Liz Savage and Andrea Widener
J Natl Cancer Inst 2007 99: 1737. [Extract] [Full Text] [PDF]